Fox Business - The Power to Prosper
Search Site

Alkermes

Our new retail holding Fifth & Pacific is a high performer

EQM Capital's Mid Cap Quant portfolio performed in line with the benchmark S&P 400 Mid-Cap index (MID) in November. One of the top-performing names in the portfolio was apparel and accessory designer and marketer, Fifth & Pacific Companies ( FNP ) which was purchased for the portfolio early in November.Fifth & Pacific operates in four segments: Juicy Couture, Lucky Brand, Kate Spade and Adelington Design Group. Shares have been rising on strong fundamentals and the prospect of the company selling its Lucky Brand denim business.Another top performer in the portfolio was biopharma company Alkermes ( ALKS ). The company's product portfolio has been strengthened by its recent purchase of Elan Corporation's drug technology unit, resulting in boosted revenues. The company's legacy product Vivitrol , to treat alcohol and drug dependence, is also experiencing robust sales.Salix Pharmaceuticals ( SLXP ) was another top-performing name during the month. The company develops and sells gastrointes...

Read More

  1. Alkermes , Amylin Halted As FDA Deadline Approaches

    Shares of partners Alkermes PLC and Amylin Pharmaceuticals were halted in afternoon trading on Friday. The U.S. Food and Drug Administration is expected to decide wh...

  2. Alkermes Completes Buy of Elan Drug Technologies

    Pharmaceutical company Alkermes Inc. (NASDAQ:ALKS) on Friday completed its merger with Elan Drug Technologies, a drug formulation and manufacturing subsidiary of Ela...

  3. Eli Lilly 1Q Profit Falls 15% Amid Higher Expenses

    Eli Lilly & Co.'s (LLY) first-quarter earnings fell 15% on higher costs associated with a drug partnership and employee layoffs, while the pharmaceutical company's r...

  4. Eli Lilly 4Q Profit Jumps 28% On Better Revenue, Margins

    Eli Lilly & Co.'s (LLY) fourth-quarter earnings rose 28%, as higher sales of an antidepressant and a cancer drug helped lift overall revenue.The Indianapolis-based d...

  5. Early-Market Movers: Dearborn Bancorp, Tupperware Brands

    Stock futures were holding on to earlier gains as earnings season continues with positive results from Boeing , which offsetting a miss by Morgan Stanley .Here are s...

  6. Early Market-Movers: Crucell, Alkermes

    Stock futures were pointing to a higher opening following strong earnings from tech companies Oracle ( NASDAQ :ORCL) and Research in Motion ( RIMM ).Here are some of...

  1. Market Wrap for Wednesday, April 17: Stocks Plunge Again Along With Euro

    The U.S. stock market fell sharply on Wednesday as volatility continues to pick up on Wall Street.Concerns over global growth have caused the recent market gyrations...

  2. Health Care Sector Wrap

    During trading today, both the Health Care sector (XLV) and the S&P500 showed little movement.Although it went in the opposite direction of the market today, the ETF...

  3. Valero Energy, State Street Included in Stocks Up on High Volume Monday

    These stocks are up on high volume today:Valero Energy (NYSE:VLO) was up on high volume today, after trading at a volume of 13.4 million, or 1.9 times its average da...

  4. Medco Health Solutions, Express Scripts Included in Stocks Up on High Volume Wednesday

    Today, these stocks are up on high volume:Today, Medco Health Solutions ( MHS ) is up on high volume, trading at a volume of 20 million, or 4.5 times its average dai...

  5. Is The American Psychiatric Association losing credibility?

    Dr. Keith Ablow says new disorders can be costly

  6. US Stocks Edge Lower As Europe's Debt Flashpoints Weigh

    U.S. stocks edged lower Monday as investors fixed their attention on the standoff between Greece and its private creditors and a surge in Portugal's borrowing costs....

  7. Amylin Rallies 20% On Diabetes Drug Approval

    Shares of Amylin Pharmaceuticals rallied 20% to $14.58 on Friday's news that U.S. regulators have approved its diabetes drug Bydureon. Amylin shares have been highly...

Freebase CC-BY
Source: Alkermes on Freebase, licensed under CC-BY
Other content from Wikipedia, licensed under the GFDL